Zobrazeno 1 - 10
of 5 801
pro vyhledávání: '"Bladé J."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mateos MV; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca, Spain., Martínez-López J; Hematology Department, Hospital 12 de Octubre, Medicine Department, Medicine School of Complutense University, I+12. CNIO, Madrid, Spain., Rodriguez Otero P; Hematology Department, Cancer Center Clinica Universidad de Navarra (CCUN), Cima, CIBERONC, Pamplona, Spain., González-Calle V; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Gonzalez MS; Hematology Department, Hospital Clinico Universitario Santiago de Compostela, Santiago de Compostela, Spain., Oriol A; Clinical Hematology, Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias I Pujol, Badalona, Spain., Gutiérrez NC; Hematology Department, University Hospital of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Ríos-Tamayo R; Unidad de Gammapatías Monoclonales, Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Rosiñol L; Hematology Department, Hospital Clinic, Barcelona, Spain., Alvarez Rivas MA; Servicio de Hematología y Hemoterapia, Hospital Universitario Reina Sofía, Córdoba, Spain., Bargay J; Hematology Department, Hospital Universitario Son Llatzer, IdISBa (Institut d'Investigació Sanitaria Illes Balears), Palma, Spain., Gonzalez-Rodriguez AP; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Alegre A; Hematology Department, University Hospital La Princesa & University Hospital QuironSalud, Autonoma-University, Madrid, Spain., Escalante F; Servicio de Hematología, Unidad i+i, Complejo Asistencial Universitario de León, León, Spain., Iñigo Rodríguez MB; Hematology Department, Hospital Clínico San Carlos, Madrid, Spain., De La Rubia J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Universidad Católica de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC CB16/12/00284, Instituto de Salud Carlos III, Madrid, Spain., Teruel AI; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., de Arriba F; Servicio de Hematologia, Hospital Universitario Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain., Palomera L; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain., Hernández MT; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez Jiménez J; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain., Reinoso-Segura M; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain., García Mateo A; Hematology Department, Complejo Asistencial de Segovia, Segovia, Spain., Ocio EM; Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain., Paiva B; Hematology Department, Clinica Universidad de Navarra, Pamplona, Spain., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain., Bladé J; Hematology Department, Hospital Clinic, IDIBARS, Barcelona, Spain., Lahuerta JJ; Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain., San-Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), CIMA, IDISNA, CIBERONC, Pamplona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20; Vol. 42 (27), pp. 3247-3256. Date of Electronic Publication: 2024 Jul 22.
Autor:
Puig N; Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC (CB16/12/00233), Salamanca, Spain., Agullo Roca C; Biochemistry Department, University Hospital of Salamanca, Salamanca, Spain., Sanfeliciano TC; Hospital de Salamanca, salamanca, Spain., Cedena MT; Hospital Universitario 12 de Octubre, Madrid, Spain., Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, Universidad Complutense, Centro Nacional de Investigaciones Oncológicas, Centro de Investigación Biomédica en Red, Madrid, Spain., Oriol A; ICO - Hosp Germans Trias i Pujol, Badalona, Spain., Blanchard MJ; Hospital Ramon y Cajal, madrid, Spain., Ríos-Tamayo R; Hospital Universitario Virgen de las Nieves, Granada, Spain., Iñigo Rodríguez B; Hospital Clínico San Carlos, Madrid, Spain., Sureda A; Institut Català d'Oncologia, Barcelona, Spain., Lakhwani S; Hospital Universitario de Canarias. Universidad de La Laguna., San Cristobal de La Laguna, Tenerife, Spain., de la Rubia Comos J; Hospital La Fe, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain, and CIBERONC, Instituto Carlos III, Madrid, Spain., Gonzalez-Calle V; Departamento de Hematología, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Cabañas V; Hospital Virgen de la Arrixaca, El Palmar. Murcia, Spain., Palomera L; Hospital Clínico Universitario, Zaragoza, Spain., Moraleda JMM; Hospital Universitario Virgen de la Arrixaca. University of Murcia, El Palmar. Murcia, Spain., Bargay J; Hospital Universitario Son LLatzer, Instituto de Investigación Sanitaria Illes Balears (IdISBa),, Palma de Mallorca, Spain., Castro S; Clinical Biochemistry Department, Hospital Universitario de Salamanca, Salamanca, Spain., Rosiñol L; Hospital Clínic, IDIBAPS, Barcelona, Spain., Bladé J; Hospital Clínic i Provincial, Institut de Investicacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., San-Miguel JF; Clinica Universidad de Navarra, CCUN, Centro de Investigación, Medica Aplicada (CIMA), Instituto de Investigación, Sanitaria de Navarra (IDISNA, CIBERONC), CIBER-ONC CB16/12/00369, Pamplona, Spain, Pamplona, Navarra, Spain., Lahuerta JJ; Instituto de Investigación.Hospital Universitario 12 de Octubre, Madrid, Spain., Paiva B; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC (CB16/12/00369), Pamplona, Spain., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Instituto de Biologia Molecular y Celular del Cancer (Universidad de Salamanca-Consejo Superior de Investigacion, Salamanca, Spain.
Publikováno v:
Blood [Blood] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.
Autor:
Sonneveld P; Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dimopoulos MA; National & Kapodistrian University of Athens, Athens, Greece., Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Quach H; University of Melbourne & St. Vincent's Hospital, Melbourne, Australia., Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital & University of Sydney, Camperdown, NSW, Australia., Beksac M; Ankara University, Ankara, Turkey., Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France., Antonioli E; Department of Hematology, Careggi Hospital & University of Florence, Firenze, Italy., Leleu X; University of Poitiers, CHU & Inserm 1313, Poitiers, France., Mangiacavalli S; Division of Hematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy., Perrot A; CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli,' Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Belotti A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Broijl A; Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gay F; Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino & Department of Molecular Biotechnology & Health Sciences, University of Torino, Torino, Italy., Mina R; Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino & Department of Molecular Biotechnology & Health Sciences, University of Torino, Torino, Italy., van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Katodritou E; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway, & KG Jebsen Center for B-cell Malignancies, University of Oslo, Oslo, Norway., Balari AS; Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain., Rosiñol L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Delforge M; University of Leuven, Leuven, Belgium., Roeloffzen W; University Medical Center Groningen, Groningen, The Netherlands., Silzle T; Department of Medical Oncology & Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Vangsted A; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Spencer A; Malignant Haematology & Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia., Hajek R; Department of Hematooncology, University Hospital Ostrava & Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Jurczyszyn A; Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Medical College, Kraków, Poland., Lonergan S; Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ahmadi T; Genmab US, Inc., Plainsboro, NJ, USA., Liu Y; Janssen Research & Development, LLC, Beijing, China., Wang J; Janssen Research & Development, LLC, Spring House, PA, USA., Vieyra D; Janssen Research & Development, LLC, Spring House, PA, USA., van Brummelen EMJ; Janssen Research & Development, LLC, Leiden, The Netherlands., Vanquickelberghe V; Janssen Research & Development, Beerse, Belgium., Sitthi-Amorn A; Janssen Research & Development, LLC, Spring House, PA, USA., de Boer CJ; Janssen Research & Development, LLC, Leiden, The Netherlands., Carson R; Janssen Research & Development, LLC, Spring House, PA, USA., Rodriguez-Otero P; Department of Hematology, Cancer Center Clínica Universidad de Navarra, Pamplona, Navarra, Spain., Bladé J; Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, & Grupo Español de Mieloma-Programa Español de Tratamientos en Hematología (GEM/PETHEMA), Barcelona, Spain., Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Sep 17, pp. 1-21. Date of Electronic Publication: 2024 Sep 17.
Autor:
Lozano E; Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona (UB), Barcelona, Spain.; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Mena MP; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Garrabou G; Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences-University of Barcelona, Barcelona, Spain., Cardús O; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Díaz T; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, Faculty of Medicine and Health Sciences, University of Barcelona, IDIBAPS, Barcelona, Spain., Moreno DF; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Mañé-Pujol J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Oliver-Caldés A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Battram A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Tovar N; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Cibeira MT; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Rodríguez-Lobato LG; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Bladé J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Fernández de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Rosiñol L; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3944-3955.
Autor:
Muchtar E; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Wisniowski B; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Geyer S; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Palladini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Milani P; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Merlini G; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Schönland S; Medical Department V, Amyloidosis Center, University of Heidelberg, Germany., Veelken K; Medical Department V, Amyloidosis Center, University of Heidelberg, Germany., Hegenbart U; Medical Department V, Amyloidosis Center, University of Heidelberg, Germany., Leung N; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Liedtke M; Stanford Amyloid Center, Stanford University School of Medicine, Stanford, California., Ulloa P; Stanford Amyloid Center, Stanford University School of Medicine, Stanford, California., Sanchorawala V; Section of Hematology and Oncology, Amyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts., Szalat R; Section of Hematology and Oncology, Amyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts., Dooley K; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Landau H; Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Petrlik E; Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lentzsch S; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York., Coltoff A; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York., Bladé J; Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain., Cibeira MT; Department of Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain., Cohen O; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Foard D; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Gillmore J; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Lachmann H; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Wechalekar A; National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, England., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01.
Autor:
JESUS SAN MIGUEL
Publikováno v:
Blood. 124:1201-1201
Autor:
Puig N; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Agulló C; Biochemistry Department, University Hospital of Salamanca, Salamanca., Contreras T; Biochemistry Department, University Hospital of Salamanca, Salamanca., Pérez JJ; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Aires I; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Calasanz MJ; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., García-Sanz R; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Castro S; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Martínez-López J; Hematology Department, Hospital 12 de Octubre, Medicine Department, Medicine School of Complutense University, I+12. CNIO, Madrid., Rodríguez-Otero P; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., González-Calle V; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., González MS; Hematology Department, Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela., Oriol A; Clinical Hematology, Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias I Pujol, Badalona., Gutiérrez NC; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Ríos-Tamayo R; Unidad de Gammapatías Monoclonales. Hospital Universitario Puerta de Hierro, Majadahonda., Rosiñol L; Hematology Department, Hospital Clinic, IDIBARS, Barcelona., Álvarez MÁ; Hematology Department, Hospital Universitario Reina Sofía, Córdoba., Bargay J; Hematology Department, Hospital Universitario Son Llatzer, IdISBa (Institut d'Investigació Sanitaria Illes Balears), Palma., González-Rodríguez AP; Hematology Department, Hospital Universitario Central de Asturias, Oviedo., Alegre A; University Hospital La Princesa and University Hospital QuironSalud, Autónoma University, Madrid., Escalante F; Servicio de Hematología, Unidad i+i, Complejo Asistencial Universitario de León, León., Iñigo MB; Hematology Department, Hospital Clínico San Carlos, Madrid., De la Rubia J; Hematology Department, Hospital Universitario y Politécnico La Fe, Universidad Católica de Valencia, CIBERONC, Valencia., Teruel AI; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia., De Arriba F; Hematology Department, Hospital Universitario Morales Meseguer, IMIBPascual., Palomera L; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria de Aragón, Zaragoza., Hernández MT; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife., López-Jiménez J; Hematology Department, Hospital Ramón y Cajal, Madrid., Reinoso M; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Sevilla., García-Mateo A; Hematology Department, Complejo Asistencial de Segovia, Segovia., Ocio EM; Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander., Bladé J; Hematology Department, Hospital Clinic, IDIBARS, Barcelona., Lahuerta JJ; Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid., Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid., Paiva B; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., Miguel JFS; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., Mateos MV; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca. mvmateos@usal.es.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 11. Date of Electronic Publication: 2024 Jul 11.
Autor:
González-Calle V; Department of Hematology, University Hospital of Salamanca (CAUSA/IBSAL) and Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca., Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra, CIMA; IDISNA; CIBERONC, Pamplona. paurodriguez@unav.es., Sureda A; Serve d'Hematologia Clínica, Institut Català D'Oncologia-L'Hospitalet. IDIBELL, Universitat de Barcelona, Barcelona., De Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia., Reinoso M; Hospital Universitario Virgen del Rocío, Sevilla., Ribas P; Hospital Universitario Dr. Peset, Valencia., González-Rodríguez AP; Hospital Universitario Central de Asturias, Oviedo., González Y; Institut Catalá D'Oncologia Girona, Girona., Oriol A; Institut Catalá D'Oncologia Badalona, Badalona., Martínez-López J; Hospital Universitario 12 de Octubre, Madrid., González MS; Complejo Hospitalario Universitario de Santiago, La Coruña., Hernández MT; Hospital Universitario de Canarias, Tenerife., Sirvent M; Hospital Donostia, San Sebastián., Cedena T; Hospital Universitario 12 de Octubre, Madrid., Puig N; Department of Hematology, University Hospital of Salamanca (CAUSA/IBSAL) and Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca., Paiva B; Cancer Center Clínica Universidad de Navarra, CIMA; IDISNA; CIBERONC, Pamplona., Bladé J; Hospital Clinic i Provincial de Barcelona, IDIBAPS, Barcelona., Lahuerta JJ; Hospital Universitario 12 de Octubre, Madrid., San-Miguel JF; Cancer Center Clínica Universidad de Navarra, CIMA; IDISNA; CIBERONC, Pamplona., Mateos MV; Department of Hematology, University Hospital of Salamanca (CAUSA/IBSAL) and Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2219-2228. Date of Electronic Publication: 2024 Jul 01.
Autor:
Lakhwani S; Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife. sunillakhwani@hotmail.com., Rosiñol L; Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona., Puig N; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca., Pico-Picos MA; Hospital Universitario de Canarias, Tenerife., Medina-González L; Hospital Universitario de Canarias, Tenerife., Martínez-López J; Hospital Universitario 12 de Octubre, Universidad Complutense, Spanish National Cancer Research Center (CNIO), Madrid., Paiva B; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona., Cedena MT; Hospital Universitario 12 de Octubre, Madrid., Oriol A; Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Institut Josep Carreras, Badalona., Ríos-Tamayo R; Hospital Universitario Puerta de Hierro, Madrid., Blanchard MJ; Hospital Universitario Ramón y Cajal, Madrid., Jarque I; Hospital Universitari i Politecnic La Fe, Valencia., Bargay J; Hospital Son Llàtzer, IdIsBa, Palma de Mallorca., Moraleda JM; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Pascual Parrilla, University of Murcia, Murcia., Carrillo-Cruz E; Hospital Universitario V. Rocio, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Sevilla., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona., Krsnik I; Hospital Universitario Puerta de Hierro, Madrid., González E; Hospital Universitario de Cabueñes, Gijón., Casado LF; Hospital General Universitario de Toledo, Toledo., Martí JM; Hospital Universitari Mútua de Terrassa, Terrassa., Encinas C; Hospital General Universitario Gregorio Marañon, IiSGM, Madrid., De Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia., Palomera L; Hospital Clínico Universitario 'Lozano Blesa', Zaragoza., Sampol A; Hospital Universitario Son Espases, Palma de Mallorca., González-Montes Y; Hospital Universitari Dr. Josep Trueta, ICO Girona, Girona., Motlló C; Hospital Althaia, Xarxa Assistencial de Manresa, Manresa., De La Cruz J; Hospital Universitario 12 De Octubre, Instituto de Investigación Sanitaria, Madrid., Alonso R; Hospital Universitario 12 de Octubre, Madrid., Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca., Bladé J; Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona., Lahuerta JJ; Hospital Universitario 12 De Octubre, Instituto de Investigación Sanitaria, Madrid., San-Miguel J; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona., Hernández MT; Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife.
Publikováno v:
Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1909-1917. Date of Electronic Publication: 2024 Jun 01.